CBX1 and breast carcinoma: These results partly agree with report by Young-Ho Lee and colleagues that high CBX1 expression group displayed more aggressive types of breast cancers, including Basal-like and Luminal B subtypes, and associated with shorter disease-free survival (DFS) and overall survival (OS) [38].